Ibrutinib, but not zanubrutinib, induces platelet receptor shedding of GPIb-IX-V complex and integrin α(IIb)β(3) in mice and humans

The Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib has proven to be efficacious in the treatment of B-cell chronic lymphocytic leukemia (B-CLL) and related diseases. However, a major adverse side effect of ibrutinib is bleeding, including major hemorrhages. The bleeding associated with ibrutinib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Dobie, Gasim, Kuriri, Fahd A., Omar, Musab M. A., Alanazi, Fehaid, Gazwani, Ali M., Tang, Chloe P. S., Sze, Daniel Man-yuen, Handunnetti, Sasanka M., Tam, Constantine, Jackson, Denise E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2019
Assuntos:
Thrombosis and Hemostasis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6929381/
https://ncbi.nlm.nih.gov/pubmed/31869418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000640
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados